HEMOGENYX PHARMA PLC (HOPHF)
HOPHF moved a median of 0.00% 30 minutes after news, and -5.00% by the close. How HOPHF actually reacts to news — the realized, point-in-time move the market made, measured across 135 labeled events over its full measured history with zero look-ahead.
HOPHF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 0% | 3 |
| 30-min | 0.00% | 0% | 3 |
| 60-min | 0.00% | 0% | 3 |
| to close | -5.00% | 0% | 3 |
| Middle 50% of HOPHF reactions | -2.50% to 0.00% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 135 |
Half of all HEMOGENYX PHARMA PLC news events land between -2.50% and +0.00% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when HOPHF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to HOPHF's baseline. Nothing else.
Recent HOPHF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Notice of AGM | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Final Results | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | — | |
| CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC - Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Half-year Report | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Signs Letter of Intent | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender | Press release | ACCESS Newswire | — | — | |
| Hemogenyx raises £570,000 and Director's Dealing | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Awarded Grant | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Final Results | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces First Patient Safety | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Institutional Investment | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1 | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes | Press release | ACCESS Newswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site | Press release | Accesswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing | Press release | Accesswire | — | — | |
| Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN | Press release | Accesswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the HOPHF section they belong to.
Where else HOPHF is measured.
HOPHF earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is HEMOGENYX PHARMA PLC's median reaction calculated?
Every labeled HOPHF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 135 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 0% of HOPHF's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does HOPHF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.